A Pilot Study of Intraoperative Gamma Camera Imaging During Sentinel Node Biopsy for Melanoma
Completed
- Conditions
- Melanoma
- Registration Number
- NCT00912730
- Lead Sponsor
- University of Virginia
- Brief Summary
This is a single-institution pilot study seeking preliminary evidence of the usefulness of mobile gamma cameras in patients undergoing sentinel node biopsy for melanoma.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- 18 years of age or older, AND
- plan to go to the operating room for sentinel node biopsy using technicium-99 labeled colloid.
Exclusion Criteria
- under 18 years of age,
- unable to give informed consent, OR
- not planned to go to operating room for sentinel node biopsy using technicium-99 labeled colloid.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sensitivity of the Mobile gamma camera (MGC)for detection of sentinel nodes, compared to fixed gamma camera (primary)
- Secondary Outcome Measures
Name Time Method sensitivity of the MGC for detection of sentinel nodes, compared to handheld gamma probe (secondary)
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of gamma camera imaging in sentinel lymph node detection for melanoma?
How does intraoperative gamma camera imaging compare to traditional blue dye and radiocolloid techniques in sentinel node biopsy for melanoma patients?
Which biomarkers are associated with successful sentinel node identification using intraoperative gamma cameras in melanoma cases?
What adverse events are reported with intraoperative gamma camera use during sentinel node biopsy for melanoma and how are they managed?
Are there any combination approaches involving gamma camera imaging and other modalities for improving sentinel node detection in melanoma?
Trial Locations
- Locations (1)
University of Virginia Health System
🇺🇸Charlottesville, Virginia, United States
University of Virginia Health System🇺🇸Charlottesville, Virginia, United States